CL
GILD icon

CPWM LLC’s Gilead Sciences GILD Stock Holding History

CPWM LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.34M Sell
21,787
-14,519
-40% -$916K 0.13% 109
2022
Q2 		$2.24M Buy
36,306
+13,882
+62% +$859K 0.2% 80
2022
Q1 		$1.33M Sell
22,424
-8,816
-28% -$564K 0.1% 117
2021
Q4 		$2.18M Hold
31,240
– – 0.17% 83
2021
Q3 		$2.18M Buy
31,240
+6,163
+25% +$433K 0.2% 67
2021
Q2 		$1.73M Buy
25,077
+17
+0.1% +$1.14K 0.13% 84
2021
Q1 		$1.62M Sell
25,060
-221
-0.9% -$14.3K 0.14% 102
2020
Q4 		$1.47M Buy
25,281
+362
+1% +$21.8K 0.13% 106
2020
Q3 		$1.57M Sell
24,919
-267
-1% -$18.5K 0.17% 92
2020
Q2 		$1.94M Sell
25,186
-5,419
-18% -$415K 0.22% 76
2020
Q1 		$2.29M Buy
30,605
+557
+2% +$38.5K 0.33% 58
2019
Q4 		$1.95M Sell
30,048
-1
-0% -$65 0.24% 77
2019
Q3 		$1.9M Buy
30,049
+593
+2% +$38.8K 0.25% 71
2019
Q2 		$1.99M Buy
29,456
+16,219
+123% +$1.07M 0.28% 65
2019
Q1 		$861K Buy
13,237
+52
+0.4% +$3.46K 0.12% 123
2018
Q4 		$825K Sell
13,185
-202
-2% -$14.1K 0.14% 110
2018
Q3 		$1.03M Sell
13,387
-2,874
-18% -$217K 0.15% 105
2018
Q2 		$1.15M Buy
16,261
+649
+4% +$45.8K 0.17% 103
2018
Q1 		$1.18M Buy
15,612
+10,969
+236% +$872K 0.18% 99
2017
Q4 		$333K Buy
4,643
+32
+0.7% +$2.43K 0.08% 158
2017
Q3 		$374K Sell
4,611
-1,668
-27% -$128K 0.09% 155
2017
Q2 		$444K Sell
6,279
-739
-11% -$49.2K 0.1% 141
2017
Q1 		$477K Sell
7,018
-2,148
-23% -$151K 0.11% 126
2016
Q4 		$656K Sell
9,166
-465
-5% -$34.6K 0.15% 108
2016
Q3 		$762K Buy
9,631
+915
+10% +$74.3K 0.17% 106
2016
Q2 		$727K Sell
8,716
-629
-7% -$55.8K 0.16% 103
2016
Q1 		$858K Sell
9,345
-2,029
-18% -$183K 0.19% 101
2015
Q4 		$1.15M Buy
11,374
+539
+5% +$56.1K 0.23% 81
2015
Q3 		$1.06M Buy
10,835
+7,374
+213% +$819K 0.23% 84
2015
Q2 		$405K Buy
+3,461
New +$378K 0.1% 129

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPWM LLC's GILD Position: Q3 2022 in Review

CPWM LLC reduced its Gilead Sciences (GILD) stake by 40% in Q3 2022, selling an estimated $916K and leaving 21,787 shares worth $1.34M. The position accounts for 0.13% of the portfolio, ranked #109.

CPWM LLC first reported a position in GILD in Q2 2015 and has held it in 30 quarters since. The position peaked at $2.29M in Q1 2020. 1,604 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • CPWM LLC held 21,787 shares of Gilead Sciences worth $1.34M as of Q3 2022.
  • CPWM LLC sold 14,519 Gilead Sciences shares in Q3 2022, an estimated $916K.
  • Gilead Sciences made up 0.13% of CPWM LLC's portfolio in Q3 2022, its #109 holding.
  • CPWM LLC first reported a position in Gilead Sciences in Q2 2015 and has held it in 30 quarters since.
  • CPWM LLC's Gilead Sciences position peaked at $2.29M in Q1 2020.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on CPWM LLC's 13F filing for Q3 2022, filed 14 Nov 2022.